Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial
Authors:
Open Access
- 4 July 2023
- journal article
- research article
- Published by Springer Nature in Frontiers of Medicine
- Vol. 17 (5) , 878-888
Abstract
Metastases of uveal melanoma (UM) spread predominantly to the liver. Due to low response rates to systemic therapies, liver-directed therapies (LDT) are commonly used for tumor control. The impact of LDT on the response to systemic treatment is unknown. A total of 182 patients with metastatic UM treated with immune checkpoint blockade (ICB) were included in this analysis. Patients were recruited from prospective skin cancer centers and the German national skin cancer registry (ADOReg) of the German Dermatologic Cooperative Oncology Group (DeCOG). Two cohorts were compared: patients with LDT (cohort A, n = 78) versus those without LDT (cohort B, n = 104). Data were analyzed for response to treatment, progression-free survival (PFS), and overall survival (OS). The median OS was significantly longer in cohort A than in cohort B (20.1 vs. 13.8 months; P = 0.0016) and a trend towards improved PFS was observed for cohort A (3.0 vs. 2.5 months; P = 0.054). The objective response rate to any ICB (16.7% vs. 3.8%, P = 0.0073) and combined ICB (14.1% vs. 4.5%, P = 0.017) was more favorable in cohort A. Our data suggest that the combination of LDT with ICB may be associated with a survival benefit and higher treatment response to ICB in patients with metastatic UM.Keywords
This publication has 35 references indexed in Scilit:
- Immunotherapy in melanoma: Recent advances and future directionsEuropean Journal of Surgical Oncology, 2017
- Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant MelanomaCancer Immunology Research, 2016
- Radiofrequency ablation and surgical resection of liver metastases from uveal melanomaEuropean Journal of Surgical Oncology, 2016
- Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal MelanomaAmerican Journal of Clinical Oncology, 2016
- Role of Local Radiation Therapy in Cancer ImmunotherapyJAMA Oncology, 2015
- Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver MetastasesAnnals of Surgical Oncology, 2015
- Laparoscopic management of liver metastases from uveal melanomaSurgical Endoscopy, 2015
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancerNature, 2015
- Very Long-Term Prognosis of Patients with Malignant Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2003
- Assessment of Metastatic Disease Status at Death in 435 Patients With Large Choroidal Melanoma in the Collaborative Ocular Melanoma Study (COMS)Archives of Ophthalmology (1950), 2001